These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8877126)

  • 1. Increasing doses of purified influenza virus hemagglutinin and subvirion vaccines enhance antibody responses in the elderly.
    Keitel WA; Cate TR; Atmar RL; Turner CS; Nino D; Dukes CM; Six HR; Couch RB
    Clin Diagn Lab Immunol; 1996 Sep; 3(5):507-10. PubMed ID: 8877126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High doses of purified influenza A virus hemagglutinin significantly augment serum and nasal secretion antibody responses in healthy young adults.
    Keitel WA; Couch RB; Cate TR; Hess KR; Baxter B; Quarles JM; Atmar RL; Six HR
    J Clin Microbiol; 1994 Oct; 32(10):2468-73. PubMed ID: 7814484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a recombinant hemagglutinin expressed in insect cells as an influenza vaccine in young and elderly adults.
    Treanor JJ; Betts RF; Smith GE; Anderson EL; Hackett CS; Wilkinson BE; Belshe RB; Powers DC
    J Infect Dis; 1996 Jun; 173(6):1467-70. PubMed ID: 8648221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine.
    Clements ML; Murphy BR
    J Clin Microbiol; 1986 Jan; 23(1):66-72. PubMed ID: 3700610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influenza vaccines: the effect of vaccine dose on antibody response in primed populations during the ongoing interpandemic period. A review of the literature.
    Palache AM; Beyer WE; Lüchters G; Völker R; Sprenger MJ; Masurel N
    Vaccine; 1993; 11(9):892-908. PubMed ID: 8212834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic and local antibody responses in elderly subjects given live or inactivated influenza A virus vaccines.
    Powers DC; Sears SD; Murphy BR; Thumar B; Clements ML
    J Clin Microbiol; 1989 Dec; 27(12):2666-71. PubMed ID: 2592535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of an influenza hemagglutinin-diphtheria toxoid conjugate vaccine in elderly nursing home subjects during an influenza outbreak.
    Gravenstein S; Drinka P; Duthie EH; Miller BA; Brown CS; Hensley M; Circo R; Langer E; Ershler WB
    J Am Geriatr Soc; 1994 Mar; 42(3):245-51. PubMed ID: 8120307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In elderly persons live attenuated influenza A virus vaccines do not offer an advantage over inactivated virus vaccine in inducing serum or secretory antibodies or local immunologic memory.
    Powers DC; Fries LF; Murphy BR; Thumar B; Clements ML
    J Clin Microbiol; 1991 Mar; 29(3):498-505. PubMed ID: 2037667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In previously immunized elderly adults inactivated influenza A (H1N1) virus vaccines induce poor antibody responses that are not enhanced by liposome adjuvant.
    Powers DC; Hanscome PJ; Pietrobon PJ
    Vaccine; 1995 Oct; 13(14):1330-5. PubMed ID: 8585289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of mucosal antibodies by live attenuated and inactivated influenza virus vaccines in the chronically ill elderly.
    Gorse GJ; Otto EE; Powers DC; Chambers GW; Eickhoff CS; Newman FK
    J Infect Dis; 1996 Feb; 173(2):285-90. PubMed ID: 8568287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of immunoglobulin G antibody responses after administration of live and inactivated influenza A vaccine indicates that nasal wash immunoglobulin G is a transudate from serum.
    Wagner DK; Clements ML; Reimer CB; Snyder M; Nelson DL; Murphy BR
    J Clin Microbiol; 1987 Mar; 25(3):559-62. PubMed ID: 3571460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trials of monovalent influenza A/New Jersey/76 virus vaccines in adults: reactogenicity, antibody response, and antibody persistence.
    Cate TR; Couch RB; Kasel JA; Six HR
    J Infect Dis; 1977 Dec; 136 Suppl():S450-5. PubMed ID: 342620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical efficacy of a prototype DNA vaccine: enhanced protection against antigenic drift in influenza virus.
    Donnelly JJ; Friedman A; Martinez D; Montgomery DL; Shiver JW; Motzel SL; Ulmer JB; Liu MA
    Nat Med; 1995 Jun; 1(6):583-7. PubMed ID: 7585127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum IgG subclass antibody responses in children vaccinated with influenza virus antigens by live attenuated or inactivated vaccines.
    Garcon NM; Groothuis J; Brown S; Lauer B; Pietrobon P; Six HR
    Antiviral Res; 1990 Aug; 14(2):109-16. PubMed ID: 2275526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elicitation of Protective Antibodies against 20 Years of Future H3N2 Cocirculating Influenza Virus Variants in Ferrets Preimmune to Historical H3N2 Influenza Viruses.
    Allen JD; Jang H; DiNapoli J; Kleanthous H; Ross TM
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization with a low dose of hemagglutinin-encoding plasmid protects against 2009 H1N1 pandemic influenza virus in mice.
    Fang J; Chen Z; Liu X; Li H; Wang J; Shen X; Chen W; Liu Y; Wang Y; Zhao P; Qi Z
    J Virol Methods; 2011 May; 173(2):314-9. PubMed ID: 21392537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and immunogenicity of a recombinant protein influenza A vaccine in adult human volunteers and protective efficacy against wild-type H1N1 virus challenge.
    Fries LF; Dillon SB; Hildreth JE; Karron RA; Funkhouser AW; Friedman CJ; Jones CS; Culleton VG; Clements ML
    J Infect Dis; 1993 Mar; 167(3):593-601. PubMed ID: 8440931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-related safety and immunogenicity of a trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine in elderly adults.
    Treanor JJ; Schiff GM; Couch RB; Cate TR; Brady RC; Hay CM; Wolff M; She D; Cox MM
    J Infect Dis; 2006 May; 193(9):1223-8. PubMed ID: 16586358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of a single amino acid substitution in the hemagglutinin molecule by chicken eggs can render influenza A virus (H3) candidate vaccine ineffective.
    Kodihalli S; Justewicz DM; Gubareva LV; Webster RG
    J Virol; 1995 Aug; 69(8):4888-97. PubMed ID: 7609057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.
    Treanor JJ; Wilkinson BE; Masseoud F; Hu-Primmer J; Battaglia R; O'Brien D; Wolff M; Rabinovich G; Blackwelder W; Katz JM
    Vaccine; 2001 Feb; 19(13-14):1732-7. PubMed ID: 11166898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.